Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation

A rapid and affordable point-of-care test is a priority for Neisseria gonorrhoeae control. WHO and Foundation for Innovative New Diagnostics (FIND) have a target product profile for a non-molecular N gonorrhoeae rapid point-of-care test that requires a clinical sensitivity of greater than 80% and a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2024-02, Vol.403 (10427), p.657-664
Hauptverfasser:	Peters, Remco P H, Klausner, Jeffrey D, Mazzola, Laura, Mdingi, Mandisa M, Jung, Hyunsul, Gigi, Ranjana M S, Piton, Jeremie, Daniels, Joseph, de Vos, Lindsey, Adamson, Paul C, Gleeson, Birgitta, Ferreyra, Cecilia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antibiotics Antigens Antimicrobial agents Antimicrobial resistance Assaying Automation Chlamydia Infections - diagnosis Chlamydia trachomatis Cross-Sectional Studies Drug resistance Female Females Gonorrhea Gonorrhea - diagnosis Health care Health care facilities Humans Immunoassay Infections Laboratories Laboratory tests Low income groups Male Males Neisseria gonorrhoeae Optimization Performance evaluation Point-of-Care Systems Polymerase chain reaction Sensitivity Sensitivity and Specificity Sexually transmitted diseases STD Urine Vagina Vaginal Discharge Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!